Bank of Montreal’s Aspire Biopharma ASBP Stock Holding History

Bank of Montreal’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-59	Closed	-$733K	–	4277
2022 Q4	$733K	Sell	59 -46	-44%	-$563K	﹤0.01%	2375
2022 Q3	$1.27K	Sell	105 -8	-7%	-$96.6K	﹤0.01%	2045
2022 Q2	$1.36K	Buy	+113	New	+$1.35M	﹤0.01%	2117

Other funds holding ASBP

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Bank of Montreal's ASBP Position: Q1 2023 in Review

Bank of Montreal sold out of Aspire Biopharma (ASBP) in Q1 2023, closing a stake of 59 shares — an estimated $733K sold.

Bank of Montreal first reported a position in ASBP in Q2 2022 and held it in 3 quarters. The position peaked at $733K in Q4 2022. 57 funds tracked by Wall St. Rank hold ASBP as of Q1 2023.

Bank of Montreal reported no remaining Aspire Biopharma position as of Q1 2023 after selling out during the quarter.
Bank of Montreal sold 59 Aspire Biopharma shares in Q1 2023, an estimated $733K.
Bank of Montreal first reported a position in Aspire Biopharma in Q2 2022 and held it in 3 quarters.
Bank of Montreal's Aspire Biopharma position peaked at $733K in Q4 2022.
57 funds tracked by Wall St. Rank held Aspire Biopharma as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.